---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-023627"
form_type: "8-K"
ticker: "VIR"
cik: "0001706431"
company_name: "Vir Biotechnology, Inc."
filed_at: "2023-05-23T23:59:59+00:00"
generated_at: "2026-06-14T17:24:05.168274+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vir Biotechnology annual meeting: directors elected, say-on-pay and auditor ratified

## Summary
- Stockholders elected Robert More, Janet Napolitano, Vicki Sato, and Elliott Sigal as Class I directors; each received over 98M votes for.
- Advisory vote on executive compensation approved: 106.0M for, 4.4M against, 97K abstentions, 8.3M broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 118.7M for, 41.7K against, 109.8K abstentions.

## SEC filing metadata
- accession: 0000950170-23-023627
- form_type: 8-K
- ticker: VIR
- cik: 0001706431
- company_name: Vir Biotechnology, Inc.
- filed_at: 2023-05-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/0000950170-23-023627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/vir-20230519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-023627
- JSON: https://secwatch.observer/filing/0000950170-23-023627.json
- Plain text: https://secwatch.observer/filing/0000950170-23-023627.txt

## Key facts
- Shareholder Votes
  Vir Biotechnology, Inc. shareholders approved Election of four Class I Directors at the 2023-05-19 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-19
  source text: Proposal 1. Election of Directors The Company’s stockholders elected the four persons listed below as Class I Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/0000950170-23-023627-index.htm
- Shareholder Votes
  Vir Biotechnology, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-05-19 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-05-19
  source text: Proposal 2. Advisory Vote on Executive Compensation The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/0000950170-23-023627-index.htm
- Shareholder Votes
  Vir Biotechnology, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2023-05-19 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-19
  source text: Proposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment by the Audit Committee
  evidence_url: https://www.sec.gov/Archives/edgar/data/1706431/000095017023023627/0000950170-23-023627-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.